Be up
to date.

Latest press release

Professor Dr Qizhuang Jin (Peking University First Hospital Nephrology Department, China) spoke to LINC Today about the recently published results of the first randomised controlled trial (RCT) comparing the APERTO® drug-coated balloon (DCB) with high pressure angioplasty balloon in the treatment of arteriovenous fistulae (AVF) lesions.

In a Q&A with LINC Today, Michael Lichtenberg, angiologist at Klinikum Hochsauerland GmbH, Arnsberg, Germany, discussed the APERTO® OTW (over-the-wire) drug coated balloon (DCB) currently being trialled in haemodialysis patients with central venous stenosis (CVS) in a bid to improve patency of arteriovenous fistulas (AVFs).

Guest from Europe: Prof. Michael Lichtenberg (Germany) & Prof. Matteo Tozzi (Italy).

Video of European guests' speech.

APERTO®, our innovative paclitaxel coated balloon for arterio-venous access, has received market approval for China. It is the the first high pressure drug coated balloon available in China to treat obstructive lesions of native Arterio Venous Dialysis Fistulae.

The approval was given based on the statistic results from the solidly designed clinical study in Chinese population:

European Key Opinion Leaders as guests:

  • Prof. Dr. Horst Sievert , Frankfurt, Germany
  • Prof. Dr. Giuseppe Tarantini, Padua, Italy
  • Prof. Dr. Jacques Blacher, Paris, France

Video of European guests' speech.

RESTORE®, CARDIONOVUM’s innovative paclitaxel-coated balloon for coronary applications has received market approval for China, making it the first drug-coated balloon (DCB) available in China to treat two indications: in-stent restenosis (ISR) and small vessel disease (SVD). The approval was given based on the impressive results from two solidly designed clinical studies in Chinese populations: RESTORE ISR CHINA and RESTORE SVD CHINA.

Upcoming events

Cardionovum® at CIRSE 2024

Cardionovum® is glad to inform that will attend CIRSE 2024.


CCL – Lisbon Congress Centre
Praça das Industrias 1
1300-307 Lisbon

Date: Sep 14, 2024–Sep 18, 2024

Latest events

Cardionovum® at Deutschen Gesellschaft für Kardiologie (DGK) 2023

Cardionovum® is glad to invite you to visit us at booth #017


Congress Center Rosengarten Mannheim (CCR)
Rosengartenplatz 2, 68161
Mannheim, Germany

Date: Apr 12, 2023–Apr 15, 2023

Cardionovum® is glad to invite you to attend the scientific session:

Clinical Scenario: DES, BRS & DCB - New Insights

  • Dott. Keeble will disclose his presentation entitled “DCB-alone PCI in De Novo Lesions: Exploring New Frontiers with RESTORE® DCB”

    Monday 5th December at 09:15h
    Hall H


David Intercontinental Convention Center
12 Kaufman St,
Tel Aviv, 61501 Israel

Date: Dec 05, 2022

Learn more >>

Cardionovum® at CSC 2022

Cardionovum® is delighted to announce the release of the XLIMIT Randomized Clinical Trial data.

  • Dr. Luca Testa, the PI of the study, will share his findings on the topic of:
    OCT-based analysis of XLIMUS® DES vs. SYNERGY DES

    Thursday 16th November at 17:45h


Hotel Riu Plaza España
Calle Gran Vía, 84,
28013, Madrid, Spain

You are welcome to visit us at booth #2

Date: Nov 16, 2022

Learn more >>

go top